Related Experiment Video
Updated: Feb 14, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Fungal infections in patients with inflammatory bowel disease: A systematic review
George A Stamatiades1,2, Petros Ioannou1,3, George Petrikkos4
1Infectious Diseases Working Group, Society of Junior Doctors, Athens, Greece.
Background:
Despite reports of fungal infections in patients with inflammatory bowel disease (IBD), their clinical and microbiological characteristics remain unknown.
Objectives:
The aim of this systematic review was to examine all available evidence regarding fungal infections in patients with IBD.
Methods:
Systematic search of PubMed (through 27 May 2017) for studies providing data on clinical, microbiological, treatment and outcome data of fungal infections in patients with IBD. The primary study outcome was to record the most common fungal species in patients with IBD. Secondary outcomes were classified into 3 categories: (i) characteristics of fungal infections; (ii) data on IBD and (iii) treatment and outcomes of fungal infections in patients with IBD.
Results:
Fourteen studies with data on 1524 patients were included in final analysis. The most common fungal infections in patients with IBD were caused by Candida species (903 infections); the most commonly reported site of Candida infection was the gastrointestinal tract. Available evidence shows that most fungal infections occur within 12 months of IBD treatment and within 6 months when anti-TNFa agents are used.
Conclusions:
This systematic review thoroughly describes fungal infections in patients with IBD and provides important information for the early detection and management of these infections.
Insights
Fungal infections, primarily Candida, are common in inflammatory bowel disease (IBD) patients, often affecting the GI tract. Early detection and management are crucial for these patients.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Mycology
Background:
- Fungal infections in inflammatory bowel disease (IBD) patients are reported but lack detailed clinical and microbiological characterization.
- Understanding these infections is critical for patient management.
Purpose of the Study:
- To systematically review existing evidence on fungal infections in patients with IBD.
- To identify common fungal species, infection characteristics, and outcomes.
Main Methods:
- A systematic literature search was conducted on PubMed up to May 2017.
- Included studies provided data on clinical, microbiological, treatment, and outcome data of fungal infections in IBD patients.
- Primary outcome: most common fungal species. Secondary outcomes: infection characteristics, IBD data, treatment, and outcomes.
Main Results:
- Fourteen studies involving 1524 patients were analyzed.
- Candida species were the most common cause of fungal infections (903 cases), predominantly in the gastrointestinal tract.
- Infections often occurred within 12 months of IBD treatment, and within 6 months with anti-TNFa agents.
Conclusions:
- This systematic review provides a comprehensive overview of fungal infections in IBD patients.
- Findings offer valuable insights for early detection and improved management strategies.
- Highlights the association between IBD treatments, particularly anti-TNFa agents, and the timing of fungal infections.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
07:10Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies
Published on: February 9, 2024
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Review and Preview
Percentiles are a type of fractile that partition data into...